US Patent Issued to MATAP II on Aug. 25 for "Prescription eyewear with photophobic response control and/or circadian cycle modulation capabilities" (New Hampshire Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,185, issued on Aug. 25, was assigned to MATAP II LLC (Aventura, Fla.).

"Prescription eyewear with photophobic response control and/or circadian cycle modulation capabilities" was invented by Thomas D. MacMullin (Boscawen, N.H.) and Bonnie Simmons (Boscawen, N.H.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A lens blank includes a first layer and a second layer. The first layer has an anterior surface and a posterior surface and is formed a base material and one or more energy absorptive dyes generally uniformly dispersed throughout the base material. The one or more dyes are configured to absorb electromagnetic energy. The second layer is bonded o...